Novo Nordisk realigns

Novo Nordisk A/S is planning to separate its healthcare businesses from its enzymes business to enable it to participate in industry consolidation, as the company's board has finally bowed to shareholder pressure to make

Read the full 344 word article

How to gain access

Continue reading with a
two-week free trial.